Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph A DiPaolo

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Current Drug Discovery Technologies|November 8, 2007
Molecular approaches to cervical cancer therapyLuis M Alvarez-Salas, Joseph A DiPaolo
Expert Opinion on Biological Therapy|July 23, 2004
Advances in the development of therapeutic nucleic acids against cervical cancerJoseph A DiPaolo, Luis M Alvarez-Salas
Antiviral Therapy|October 2, 2003
Advances in the development of ribozymes and antisense oligodeoxynucleotides as antiviral agents for human papillomavirusesLuis Maret Alvarez-Salas, Maria Luisa Benítez-Hess, Joseph A DiPaolo
Oligonucleotides|August 19, 2008
A triplex ribozyme expression system based on a single hairpin ribozymeGuillermo Aquino-Jarquin, María Luisa Benítez-Hess, Joseph A DiPaolo, et al.
Archives of Medical Research|September 12, 2007
Effect of combined antisense oligodeoxynucleotides directed against the human papillomavirus type 16 on cervical carcinoma cellsMiguel A Márquez-Gutiérrez, María L Benítez-Hess, Joseph A DiPaolo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2002
Utilization of the human genome sequence localizes human papillomavirus type 16 DNA integrated into the TNFAIP2 gene in a fatal cervical cancer from a 39-year-old womanMark H Einstein, Yvette Cruz, Mustafa K El-Awady, et al.
American Journal of Obstetrics and Gynecology|January 28, 2003
Herpes simplex virus type II is not a cofactor to human papillomavirus in cancer of the uterine cervixDanh Tran-Thanh, Diane Provencher, Anita Koushik, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Current Drug Discovery Technologies|November 8, 2007
Molecular approaches to cervical cancer therapyLuis M Alvarez-Salas, Joseph A DiPaolo
Expert Opinion on Biological Therapy|July 23, 2004
Advances in the development of therapeutic nucleic acids against cervical cancerJoseph A DiPaolo, Luis M Alvarez-Salas
Antiviral Therapy|October 2, 2003
Advances in the development of ribozymes and antisense oligodeoxynucleotides as antiviral agents for human papillomavirusesLuis Maret Alvarez-Salas, Maria Luisa Benítez-Hess, Joseph A DiPaolo
Oligonucleotides|August 19, 2008
A triplex ribozyme expression system based on a single hairpin ribozymeGuillermo Aquino-Jarquin, María Luisa Benítez-Hess, Joseph A DiPaolo, et al.
Archives of Medical Research|September 12, 2007
Effect of combined antisense oligodeoxynucleotides directed against the human papillomavirus type 16 on cervical carcinoma cellsMiguel A Márquez-Gutiérrez, María L Benítez-Hess, Joseph A DiPaolo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2002
Utilization of the human genome sequence localizes human papillomavirus type 16 DNA integrated into the TNFAIP2 gene in a fatal cervical cancer from a 39-year-old womanMark H Einstein, Yvette Cruz, Mustafa K El-Awady, et al.
American Journal of Obstetrics and Gynecology|January 28, 2003
Herpes simplex virus type II is not a cofactor to human papillomavirus in cancer of the uterine cervixDanh Tran-Thanh, Diane Provencher, Anita Koushik, et al.
Pageof 1